These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 6633141

  • 1. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine].
    Roth A, Kolarić K.
    Lijec Vjesn; 1983 Jun; 105(6):244-6. PubMed ID: 6633141
    [No Abstract] [Full Text] [Related]

  • 2. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study.
    White LA, Perry MC, Kardinal CG, Kennedy BJ, Weiss RB, Carey RW.
    Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497
    [Abstract] [Full Text] [Related]

  • 3. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
    Greco FA, Richardson RL, Shulman SF, Oldham RK.
    Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
    [No Abstract] [Full Text] [Related]

  • 4. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
    Macdonald JS, Kisner DF, Smythe T, Woolley PV, Smith L, Schein PS.
    Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
    [Abstract] [Full Text] [Related]

  • 5. [Chemotherapy of cancer of the large intestine].
    Platinskiĭ LV, Sokolova VD, Ozhiganov EL.
    Sov Med; 1985 Nov; (3):51-8. PubMed ID: 3895460
    [No Abstract] [Full Text] [Related]

  • 6. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
    Togni P, Sessa C, Varini M, Cavalli F.
    Schweiz Med Wochenschr; 1982 Jun 26; 112(26):930-3. PubMed ID: 6214002
    [Abstract] [Full Text] [Related]

  • 7. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
    Cedermark BJ, Kaufman JH, Douglass HO, Mittelman A.
    Clin Oncol; 1977 Mar 26; 3(1):27-31. PubMed ID: 862274
    [No Abstract] [Full Text] [Related]

  • 8. Phase II study of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin in advanced colorectal cancer. By the Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1984 Jul 26; 2(7):770-3. PubMed ID: 6234380
    [Abstract] [Full Text] [Related]

  • 9. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer.
    Buroker T, Wojtaszak B, Dindogru A, DeMattia M, Baker L, Groth C, Vaitkevicius VK.
    Cancer Treat Rep; 1978 May 26; 62(5):689-92. PubMed ID: 350398
    [Abstract] [Full Text] [Related]

  • 10. Systemic cytostatic drug therapy in liver cancer.
    Glimelius B.
    Ann Chir Gynaecol Suppl; 1986 May 26; 200():69-73. PubMed ID: 3014989
    [No Abstract] [Full Text] [Related]

  • 11. Phase II study of melphalan in colorectal carcinoma.
    DiBenedetto J, Moayeri H, Evans JT, Mittelman A.
    Cancer Treat Rep; 1978 Sep 26; 62(9):1401-2. PubMed ID: 688286
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of advanced cancer of the colon and rectum with the combination of 5-fluorouracil, imidazolecarboxamide and vincristine].
    Fleischer I, Wainstein R, de Gibson AS.
    Medicina (B Aires); 1983 Sep 26; 43(2):143-6. PubMed ID: 6664281
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of advanced colonic and rectal adenocarcinoma: combination of 5-FU and high-dose folinic acid].
    Rougier P, Droz JP, Ducreux M, Kac J, Spielmann M, Crespon B, Ley G, Zimmermann P, Theodore C, Chavy A.
    Bull Cancer; 1983 Sep 26; 70(5):434-6. PubMed ID: 6607759
    [No Abstract] [Full Text] [Related]

  • 17. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
    Presant CA, Ratkin G, Klahr C.
    Cancer Treat Rep; 1978 Mar 26; 62(3):461-2. PubMed ID: 348317
    [No Abstract] [Full Text] [Related]

  • 18. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA, Stroehlein JR, Bennetts RW, Jones RD, Heifetz LJ, Mahal PS.
    Cancer Treat Rep; 1982 Aug 26; 66(8):1613-7. PubMed ID: 7105051
    [Abstract] [Full Text] [Related]

  • 19. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
    Kemeny N, Yagoda A, Braun D.
    Cancer; 1983 Jan 01; 51(1):20-4. PubMed ID: 6217886
    [Abstract] [Full Text] [Related]

  • 20. Phase II trial of a combination of cyclosphamide, vincristine, and methotrexate in advanced colorectal carcinoma.
    Taylor SG, Desai SA, DeWys WD.
    Cancer Treat Rep; 1978 Aug 01; 62(8):1203-5. PubMed ID: 356978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.